Cannabinoid-dependent potentiation of inhibition at eye opening in mouse V1
For a Louisiana policyholder watching their monthly premium rise every year, it was a practical choice between researchers studying inequity and a check covering this months bill - it was the difference between being studied and being served
Medication "While primary care physicians may still follow the old idea that metformin is 'first line,' I think most endocrinologists have been using GLP-1 receptor agonists and SGLT2 inhibitors as best-in-class therapy for nearly a decade," says Michael Uzmann, MD, a dual board-certified endocrinologist and internist at A1Endocrinology in Las Vegas
Glucagon-like peptide-1 (GLP-1) receptor agonists are a newer class of diabetes drugs that have the potential to double as weight loss drugs, widening their lucrative market potentials
Nowson CA, OConnell SL, et al
One of its key advantages is its selectivity, meaning it stimulates growth hormone release without significantly increasing cortisol or prolactin levels